ERIN CUNNINGHAM: Open Payments
NPI 1730519414 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 21 payments from 10 companies in 2025. Trend: 2023 $257 · 2024 $80 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $148 |
| GENZYME CORPORATION | 1 | $108 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| ARRAY BIOPHARMA INC | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $23 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Janssen Biotech, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: WAYRILZ, IBRANCE, ELREXFIO, KISQALI, BRAFTOVI, Orserdu, MONOFERRIC, DATROWAY.
Industry payments across OH — which companies pay providers there.
